SELLAS Life Sciences Group, Inc. Research And Development Expense

• SELLAS Life Sciences Group, Inc. showed an increase of +68.9% in Research And Development Expense from 2020 to 2021.
• This data is from SELLAS Life Sciences Group, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2022.
• XBRL data for this metric is available from 2010 to 2021 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: $2.26 million | Q3 2010: $1.94 million | Q1 2011: $2.16 million | Q2 2011: $329.0 thousand | Q3 2011: $1.37 million | Q1 2012: $2.66 million | Q2 2012: $3.72 million | Q3 2012: $4.17 million | Q1 2013: $5.08 million | Q2 2013: $5.28 million | Q3 2013: $3.63 million | Q1 2014: $6.77 million | Q2 2014: $8.07 million | Q3 2014: $7.03 million | Q1 2015: $5.83 million | Q2 2015: $7.20 million | Q3 2015: $5.74 million | Q1 2016: $5.44 million | Q2 2016: $6.18 million | Q3 2016: $3.62 million | Q1 2017: $2.18 million | Q2 2017: $1.83 million | Q3 2017: $1.07 million | Q1 2018: $1.80 million | Q2 2018: $1.59 million | Q3 2018: $1.72 million | Q1 2019: $1.86 million | Q2 2019: $1.38 million | Q3 2019: $1.80 million | Q1 2020: $1.86 million | Q2 2020: $2.28 million | Q3 2020: $2.37 million | Q1 2021: $4.28 million | Q2 2021: $3.46 million | Q3 2021: $4.54 million.
• Over the full 9 years of available data (2010 to 2021), SELLAS Life Sciences Group, Inc.'s Research And Development Expense has grown by 99.1%.
• Historical annual values: Fiscal year 2021: $15.67 million | Fiscal year 2020: $9.28 million | Fiscal year 2019: $7.29 million | Fiscal year 2018: $8.77 million | Fiscal year 2017: $6.07 million | Fiscal year 2016: $11.40 million | Fiscal year 2012: $14.61 million | Fiscal year 2011: $3.85 million | Fiscal year 2010: $7.87 million.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026